These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 27276711)
1. FOXC2 disease-mutations identified in lymphedema-distichiasis patients cause both loss and gain of protein function. Tavian D; Missaglia S; Maltese PE; Michelini S; Fiorentino A; Ricci M; Serrani R; Walter MA; Bertelli M Oncotarget; 2016 Aug; 7(34):54228-54239. PubMed ID: 27276711 [TBL] [Abstract][Full Text] [Related]
3. The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis. Berry FB; Tamimi Y; Carle MV; Lehmann OJ; Walter MA Hum Mol Genet; 2005 Sep; 14(18):2619-27. PubMed ID: 16081467 [TBL] [Abstract][Full Text] [Related]
5. A novel missense mutation and two microrearrangements in the FOXC2 gene of three families with lymphedema-distichiasis syndrome. Fauret AL; Tuleja E; Jeunemaitre X; Vignes S Lymphology; 2010 Mar; 43(1):14-8. PubMed ID: 20552815 [TBL] [Abstract][Full Text] [Related]
6. Imbalance between Expression of FOXC2 and Its lncRNA in Lymphedema-Distichiasis Caused by Frameshift Mutations. Missaglia S; Tavian D; Michelini S; Maltese PE; Bonanomi A; Bertelli M Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33925370 [TBL] [Abstract][Full Text] [Related]
7. Novel FOXC2 Mutation and Distichiasis in a Patient With Lymphedema-Distichiasis Syndrome. De Niear MA; Breazzano MP; Mawn LA Ophthalmic Plast Reconstr Surg; 2018; 34(3):e88-e90. PubMed ID: 29406328 [TBL] [Abstract][Full Text] [Related]
8. Novel missense mutations in the FOXC2 gene alter transcriptional activity. van Steensel MA; Damstra RJ; Heitink MV; Bladergroen RS; Veraart J; Steijlen PM; van Geel M Hum Mutat; 2009 Dec; 30(12):E1002-9. PubMed ID: 19760751 [TBL] [Abstract][Full Text] [Related]
9. A case of lymphedema-distichiasis syndrome carrying a new de novo frameshift FOXC2 mutation. Fabretto A; Shardlow A; Faletra F; Lepore L; Hladnik U; Gasparini P Ophthalmic Genet; 2010 Jun; 31(2):98-100. PubMed ID: 20450314 [TBL] [Abstract][Full Text] [Related]
10. Lymphedema-distichiasis syndrome: a distinct type of primary lymphedema caused by mutations in the FOXC2 gene. Vreeburg M; Heitink MV; Damstra RJ; Moog U; van Geel M; van Steensel MA Int J Dermatol; 2008 Nov; 47 Suppl 1():52-5. PubMed ID: 18986489 [TBL] [Abstract][Full Text] [Related]
11. Genetic landscape of FOXC2 mutations in lymphedema-distichiasis syndrome: Different mechanism of pathogenicity for mutations in different domains. Jiang L; Ren W; Xie C; Duan S; Dai C; Wei Y; Luo D; Wang T; Gong B; Liu X; Yang Z; Ye Z; Chen H; Shi Y Exp Eye Res; 2022 Sep; 222():109136. PubMed ID: 35716761 [TBL] [Abstract][Full Text] [Related]
12. Lymphedema-distichiasis syndrome and FOXC2 gene mutation. Traboulsi EI; Al-Khayer K; Matsumoto M; Kimak MA; Crowe S; Wilson SE; Finegold DN; Ferrell RE; Meisler DM Am J Ophthalmol; 2002 Oct; 134(4):592-6. PubMed ID: 12383817 [TBL] [Abstract][Full Text] [Related]
13. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Fang J; Dagenais SL; Erickson RP; Arlt MF; Glynn MW; Gorski JL; Seaver LH; Glover TW Am J Hum Genet; 2000 Dec; 67(6):1382-8. PubMed ID: 11078474 [TBL] [Abstract][Full Text] [Related]
14. A Chinese pedigree of lymphoedema-distichiasis syndrome with a novel mutation in the FOXC2 gene. Zhu LL; Lv YN; Chen HD; Gao XH Clin Exp Dermatol; 2014 Aug; 39(6):731-3. PubMed ID: 24984567 [TBL] [Abstract][Full Text] [Related]
15. Novel mutation in the FOXC2 gene in three generations of a family with lymphoedema-distichiasis syndrome. Sutkowska E; Gil J; Stembalska A; Hill-Bator A; Szuba A Gene; 2012 Apr; 498(1):96-9. PubMed ID: 22349027 [TBL] [Abstract][Full Text] [Related]
16. Lymphedema-distichiasis syndrome without FOXC2 mutation: evidence for chromosome 16 duplication upstream of FOXC2. Witte MH; Erickson RP; Khalil M; Dellinger M; Bernas M; Grogan T; Nitta H; Feng J; Duggan D; Witte CL Lymphology; 2009 Dec; 42(4):152-60. PubMed ID: 20218083 [TBL] [Abstract][Full Text] [Related]
17. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Kriederman BM; Myloyde TL; Witte MH; Dagenais SL; Witte CL; Rennels M; Bernas MJ; Lynch MT; Erickson RP; Caulder MS; Miura N; Jackson D; Brooks BP; Glover TW Hum Mol Genet; 2003 May; 12(10):1179-85. PubMed ID: 12719382 [TBL] [Abstract][Full Text] [Related]
18. Rare Variants in LAMA5 Gene associated with FLT4 and FOXC2 Mutations in Primary Lymphedema May Contribute to Severity. Liu NF; Yu ZY; Sun D; Lou Y Lymphology; 2016 Dec; 49(4):192-204. PubMed ID: 29908552 [TBL] [Abstract][Full Text] [Related]
19. Novel FOXC2 Mutation in Hereditary Distichiasis Impairs DNA-Binding Activity and Transcriptional Activation. Zhang L; He J; Han B; Lu L; Fan J; Zhang H; Ge S; Zhou Y; Jia R; Fan X Int J Biol Sci; 2016; 12(9):1114-20. PubMed ID: 27570485 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. Brice G; Mansour S; Bell R; Collin JR; Child AH; Brady AF; Sarfarazi M; Burnand KG; Jeffery S; Mortimer P; Murday VA J Med Genet; 2002 Jul; 39(7):478-83. PubMed ID: 12114478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]